Suchergebnisse - Dexamethasone OR corticosteroid

PubPharm (133)

71

Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial

enthalten in: Intensive care medicine | 2021

von Rosas, I. | Diaz, G. | Gottlieb, R. | +18

72

Risk, Course, and Effect of SARS-CoV-2 Infection in Children and Adults with Chronic Inflammatory Bowel Diseases

enthalten in: Children (Basel, Switzerland) | 2021

von Corrias, A. | Cortes, G. | Bardanzellu, F. | +3

73

Clinical efficacy and safety of combination therapy of tocilizumab and steroid pulse therapy for critical COVID-19 in HD patients

enthalten in: Clinical and experimental nephrology | 2021

von Toda, M. | Fujii, K. | Yoshifuji, A. | +5

74

Clinical efficacy and safety of combination therapy of tocilizumab and steroid pulse therapy for critical COVID-19 in HD patients

enthalten in: Clinical and experimental nephrology | 2021

von Toda, M. | Fujii, K. | Yoshifuji, A. | +5

75

Clinical efficacy and safety of combination therapy of tocilizumab and steroid pulse therapy for critical COVID-19 in HD patients

enthalten in: Clinical and experimental nephrology | 2021

von Toda, M. | Fujii, K. | Yoshifuji, A. | +5

76

Efficacy of tocilizumab in patients with severe COVID-19 : Survival and clinical outcomes

enthalten in: Journal of infection and public health | 2021

von Al-Baadani, A. | Eltayeb, N. | Alsufyani, E. | +11

77

Efficacy and safety of tocilizumab in COVID-19 patients : a living systematic review and meta-analysis, first update

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2021

von Tleyjeh, I. | Kashour, Z. | Riaz, M. | +3

CommentIn: Clin Microbiol Infect. 2021 Aug;27(8):1175-1176. - PMID 33549765

78

Dexamethasone and tocilizumab treatment considerably reduces the value of C-reactive protein and procalcitonin to detect secondary bacterial infections in COVID-19 patients

enthalten in: Critical care (London, England) | 2021

von Kooistra, E. | van Berkel, M. | van Kempen, N. | +7

79

Dexamethasone and tocilizumab treatment considerably reduces the value of C-reactive protein and procalcitonin to detect secondary bacterial infections in COVID-19 patients

enthalten in: Critical care | 2021

von Kooistra, E. | van Berkel, M. | van Kempen, N. | +7

80

Benefits of Tocilizumab in patients with a severe form of SARS-CoV-2 infection : Experience of the intensive care unit of the Mohammed VI university hospital, Oujda

enthalten in: Annals of medicine and surgery (2012) | 2021

von El Rhalete, A. | Rhazi, I. | Bensaid, A. | +10